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Bundled care in acute kidney injury in
critically ill patients, a before-after
educational intervention study
Jacqueline Koeze* , Iwan C. C. van der Horst, Renske Wiersema, Frederik Keus, Willem Dieperink, Eline G. M. Cox,
Jan G. Zijlstra and Matijs van Meurs
Abstract
Background: Acute kidney injury (AKI) often occurs in critically ill patients. AKI is associated with mortality and
morbidity. Interventions focusing on the reduction of AKI are suggested by the Kidney Disease: Improving Global
Outcomes guideline. We hypothesized that these educational interventions would improve outcome in patients
admitted to the Intensive Care Unit (ICU).
Methods: This was a pragmatic single-centre prospective observational before-after study design in an ICU in a
tertiary referral hospital. All consecutive patients admitted to the ICU irrespective their illness were included. A ‘Save
the Kidney’ (STK) bundle was encouraged via an educational intervention targeting health care providers. The
educational STK bundle consisted of optimizing the fluid balance (based on urine output, serum lactate levels and/
or central venous oxygen saturation), discontinuation of diuretics, maintaining a mean arterial pressure of at least
65 mmHg with the potential use of vasopressors and critical evaluation of the indication and dose of nephrotoxic
drugs. The primary outcome was the composite of mortality, renal replacement therapy (RRT), and progression of
AKI. Secondary outcomes were the components of the composite outcome the severity of AKI, ICU length of stay
and in-hospital mortality.
Main results: The primary outcome occurred in 451 patients (33%) in the STK group versus 375 patients (29%) in
the usual care group, relative risk (RR) 1.16, 95% confidence interval (CI) 1.03–1.3, p < 0.001. Secondary outcomes
were, ICU mortality in 6.8% versus 5.6%, (RR 1.22, 95% CI 0.90–1.64, p = 0.068), RRT in 1.6% versus 3.6% (RR 0.46, 95%
CI 0.28–0.76, p = 0.002), and AKI progression in 28% versus 24% (RR 1.18, 95% CI 1.04–1.35, p = 0.001).
Conclusions: Providing education to uniformly apply an AKI care bundle, without measurement of the
implementation in a non-selected ICU population, targeted at prevention of AKI progression was not beneficial.
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Background
Acute kidney injury (AKI) occurs in 15 to 33% of all crit-
ically ill patients [1, 2]. The initial definition of AKI was
defined as an increase in serum creatinine and/or a re-
duction in urine output by Bellomo et al. in 2004, which
was revised by Mehta et al. in 2007 and once again in
the current definition by Kidney Disease: Improving
Global Outcomes (KDIGO) in 2012 [3–5]. Irrespective
of the definition, the occurrence of AKI is associated
with increased mortality rates and also increased inci-
dences of chronic kidney disease (CKD) after discharge
[6, 7]. The severity of AKI is associated with increased
intensive care unit (ICU) and hospital mortality [8].
Despite the lack of evidence for benefit, guidelines di-
rected to prevent AKI recommend either volume resus-
citation or volume restriction, promote and dismiss
various types of fluids, pose blood pressure targets, and
emphasize avoidance of nephrotoxic drugs [5]. The rec-
ommendation of controlled fluid resuscitation is based
on observations that both hypovolemia and hypervole-
mia can induce AKI [9]. The use of artificial colloids and
(loop-) diuretics is dissuaded based on aggregated data
from randomised trials and large cohort studies [5, 10].
Nephrotoxic drugs and drug dosing should be weighed
carefully, especially in critically ill patients already at risk
for AKI [5]. Further, guidelines recommend targeting
blood pressure at a mean arterial pressure (MAP) above
60–65mmHg using vasopressors [5, 11].
A bundled approach of care for the critically ill includ-
ing these individual recommendations is suggested to
preserve renal function [5]. Care bundles targeted at the
treatment of sepsis and ventilator-associated pneumo-
nias (VAP) have improved outcomes in critically ill pa-
tients [12–14]. Bundles targeted at AKI prevention have
already been successfully tested in patients undergoing
cardiac surgery and also in hospitalized patients, but not
in a general critically ill population [15, 16].
We therefore hypothesized that the implementation of
education for bundled care targeted at prevention of




A pragmatic single-centre prospective observational
before-after study design was used. The study was per-
formed in a tertiary referral hospital. The need for in-
formed consent was waived by the Institutional Review
Board of our hospital (METc 2013–174). The Ethical
Board waived consent because the care bundle was imple-
mented at a department level and changed overall daily
practice. Patients were treated according to usual care
during the first period. After the first (‘before’) period of
the study the educational intervention was introduced at a
department level to all personnel between June 12th, 2015
and October 14th, 2015. During the second period pa-
tients were treated according to the ‘Save the Kidney’
(STK)-bundle in addition to usual care. The duration of
both study periods was estimated from admittance rates
combined with sample size calculations.
Patient selection
Consecutive patients admitted to the ICU were included
irrespective their illness. Both scheduled post-surgery pa-
tients needing postoperative ICU observation and acutely
admitted patients, both surgical and medical, were in-
cluded. Patients with known chronic kidney disease (de-
fined by a serum creatinine greater than 177 μmol/l, based
on the definition used by the Nationale Intensive Care
Evaluatie (NICE)) and patients on chronic renal replace-
ment therapy (RRT) were excluded from the analysis. If
patients were readmitted to our ICU within the study
period only data of their first admission were included in
the analysis. Patients were splitted into two groups based
on admission date, divided into two set periods of time.
Data collection
Baseline data of all patients were recorded, including
age, sex, body mass index (BMI), APACHE IV and ad-
mission category and type (medical or surgical; sched-
uled or emergency). In addition to age and severity of
illness, the presence of known diabetes mellitus was re-
corded as it is a known risk factor for AKI development.
We recorded mortality (ICU and hospital), the need for
RRT, the occurrence and severity of AKI and the length
of ICU stay. Serum creatinine was recorded each day
and urinary output was recorded hourly. The reference
creatinine was based on the ideal serum creatinine,
which was calculated assuming a clearance of 75 ml/
min/1.73m2 using the ‘modification of diet in renal dis-
ease’ (MDRD) formula. The incidence and severity of
AKI were assessed in each patient according to the
KDIGO definitions, using both serum and urine output
criteria (Supplementary figure 1). AKI progression was
defined as any progression (i.e. 0 to 1, 2 to 3, etc.) in
AKI stage during the first 48 h of admission.
The ‘save the kidney’ educational intervention bundle
The STK bundle was encouraged in all patients (Table 1).
The STK bundle consisted of optimizing the fluid balance
(based on urine output, serum lactate levels and/or central
venous oxygen saturation), discontinuation of diuretics,
maintaining a MAP of at least 65mmHg with the poten-
tial use of vasopressors and critical evaluation of the indi-
cation and dose of nephrotoxic drugs [5]. Discouraging
artificial colloids was not part of the bundle, since colloids
were already excluded in the past (Table 1). Avoidance of
hyperglycaemia as is suggested by the KDIGO guidelines
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was not part of the bundle, as we already used a compu-
terised algorithm regulating serum glucose which was the
same in both groups [17]. Close monitoring of serum cre-
atinine, also suggested by the KDIGO guidelines, was also
the same in both groups. As mentioned before we mea-
sured serum creatinine daily and urine output hourly.
The ‘STK’-bundle was introduced using introductory lec-
tures to all physicians and nurses, by the distribution of
pocket cards, and emphasized during discussions on the
wards. The specific interventions were left open for the
treating physician to make the bundle more compliant with
different personal preferences within the treating intensivist
group. We did not assess compliance with the bundle.
Outcomes
The primary outcome measure was a composite of ser-
ious adverse events (SAE’s) consisting of ICU mortality,
the need for RRT and/or the progression of AKI.
Secondary outcomes were the three individual compo-
nents of the composite primary outcome, including ICU
mortality, the need for RRT, and the progression of AKI
during the first 48 h of ICU stay. In-hospital mortality
and ICU length of stay were considered as well.
Sample size estimation
A previous study in a comparable critically ill population
observed a 30-day mortality of 17%, a cumulative inci-
dence proportion of approximately 5% for RRT and the
cumulative incidence proportion of 16% for AKI [1].
Based on these data, we estimated a cumulative risk of
25% of one or more of the SAE in the control group of
our ICU population. With a cumulative event rate of
25% in the control group, a relative risk reduction (RRR)
of 20% of SAE (which would imply a reduction of SAE
from 25 to 20%, which was considered clinically rele-
vant), a type I error of 0.05, and a type II error of 0.20,
we calculated that 1094 patients were needed in each
group of the study (and 2188 patients in total). We an-
ticipated a study period of 6 months for each group.
Statistical analysis
The proportions of AKI were calculated based on data
of the first 48 h of ICU admission. AKI severity was
calculated in all patients. Dichotomous data were pre-
sented as percentages. Continuous variables were re-
ported as means (with standard deviations (SD)) or as
medians (with interquartile ranges (IQR)) depending on
normality. Data were analysed using Student t-tests,
Mann Whitney U tests, or Chi-square tests, when appro-
priate. As a sensitivity analysis, analysis were repeated in
patients with and without diabetes mellitus.
Missing hourly urine output data were replaced based
on averages using the first recorded value over the miss-
ing hours. Urine output data were omitted from the ana-
lysis if all hourly urine output was missing.
Results
A total of 3822 patients were admitted between the start
of the study January 1st, 2014 and study closure on
March 15th, 2015. The first period was from 01 to 01-
2014 until 11-06-2014 and the second period was from
15 to 10-2014 until 15-03-2015. A total of 1295 patients
(49%) were included in the usual care group and 1347
patients (51%) were included in the STK group. (Fig. 1a).
Baseline patient characteristics
Patients in both groups were similar regarding age, sex,
BMI, severity of illness and the presence of known dia-
betes mellitus (Table 2). More patients in the STK group
were admitted for a medical reason and less patients
were admitted after scheduled surgery (Table 2). Patients
in the STK group had a lower median cumulative fluid
balance during the first 3 days of ICU admission.
Serum creatinine at admission was unavailable in 98 pa-
tients (3.7%) and in 489 patients (19%) there was insuffi-
cient data to estimate the presence or absence of AKI
based on urine output criteria on admission. Overall, the
median available hours of urine output data calculated as
a percentage of length of stay was 89% (IQR 62–95%).
Primary outcome
Serious adverse events defined as ICU mortality, the
need for RRT and/or the progression of AKI was ob-
served in 451 patients (33%) in the STK group compared
to 375 patients (29%) in the usual care group (RR 1.16,
95% confidence interval CI 1.03–1.3, p < 0.001) (Table 3).
Table 1 The ‘Save the Kidney’-bundle
Optimize fluid balance CVP 8–12mmHg
UO > 0.5 ml/kg/h




Evaluate the indication and dose of possible nephrotoxic medication
CVP Central venous pressure, UO Urinary output, SvO2 Mixed venous oxygen saturation, MAP Mean arterial pressure
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Fig. 1 Flow diagram of patients in the study. a. Numbers of patients admitted in both groups. Numbers of patients excluded due to presence of
chronic kidney disease (CKD). Numbers of patients with severity of acute kidney injury (AKI) and with stable AKI, AKI progression or regression at
admission, after 24 h of admission and after 48 h of admission. (*) Usual care group: 4 missing AKI stage at admission, 2 stage 0 after 24 h and 2
stage 1 after 24 h. Save the kidney group: 94 missing AKI stage at admission, 24 stage 0 at 24 h, 8 stage 1 at 24 h, 4 stage 2 at 24 h, 2 stage 3 at
24 h and 56 missing AKI stage after 24 h. Usual care group: 55 missing AKI stage at 24 h all remain missing after 48 h. Save the kidney group: 101
missing AKI stage at 24 h, 1 is stage 0 after 48 h, 100 are missing AKI stage at 48 h. b. Number of patients in the control group and STK group
with severity of AKI at admission and development over the first 48 h. Green squares indicate improvement in AKI during the first 48 h . Yellow
squares indicate stable AKI during the first 48 h. Red squares indicate AKI progression during the first 48 h
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Table 2 Basic patient characteristics
Characteristic Usual care group STK group P-value
Number of patients 1295 1347
Age (years; mean ± SD) 60.2 (15.6) 59.6 (16.2) 0.35
Male sex (N (%)) 809 (63) 835 (62) 0.8
Body Mass Index (kg/m2; mean ± SD) 26.5 (5.2) 26.5 (10) 0.98
APACHE IV (mean ± SD) 51 (25) 52.3 (25) 0.18
Admission type 0.05
● Medical (N (%)) 423 (33) 497 (37)
● Surgical (N (%))
○ Scheduled (N (%)) 699 (54) 665 (49)
○ Emergency (N (%)) 172 (13) 185 (14)
Co-morbidity
● Diabetes mellitus (N (%)) 194 (15) 195 (15) 0.72
Serum creatinine at admission (μmol/l; median (IQR)) 73 (59–91) 72 (59–89) 0.16
KDIGO stage admission (N (%)) 1291 (99) 1253 (93) 0.73
No AKI (N (%)) 1147 (89) 1117 (83)
Stage 1 (N (%)) 85 (6.6) 95 (7.1)
Stage 2 (N (%)) 28 (2.2) 21 (1.6)
Stage 3 (N (%)) 31 (2.4) 20 (1.5)
Fluid balance day 1 1086 (299, 2112) 728 (61, 1795) < 0.01
Fluid balance day 2 848 (194, 2260) 726 (173, 1878) 0.023
Fluid balance day 3 708 (89, 1785) 533 (−13, 1389) 0.011
STK ‘Save the Kidney’, SD Standard deviation, APACHE Acute physiology and chronic health evaluation, IQR Inter quartile range
Table 3 Primary and secondary outcomes of the ‘Save the Kidney’-bundle
Outcome Usual care group STK group RR (95%CI) P-value
Number of patients 1295 1347
Primary outcome (AKI progression, need for RRT and ICU mortality) (N (%)) 388 (30) 465 (36) 1.15 (1.03–1.29)
0.001 (*)
Overall ICU mortality (N (%)) 72 (5.6) 91 (6.8) 1.22 (0.90–1.64)
0.068 (*)
Need for RRT during ICU admission (N (%)) 46 (3.6) 22 (1.6) 0.46 (0.28–0.76)
0.002 (*)
AKI progression (N (%)) 326 (25) 402 (31) 1.19 (1.05–1.34)
0.001 (**)
Maximum AKI stage during 48 h 0.87 (0.82–0.93)
No AKI (N (%)) 863(67) 783 (61) < 0.001 (***)
AKI stage 1 (N (%)) 238 (18) 299 (23) 1.21 (1.04–1.41)
AKI stage 2 (N (%)) 128 (10) 169 (13) 1.27 (1.02–1.58)
AKI stage 3 (N (%)) 66 (5.1) 41 (3.2) 0.6 (0.41–0.88)
ICU LoS (days; median [IQR]) 2 [2–3] 2 [2–3] 0.319 (*)
Hospital mortality (N (%)) 117 (9) 137 (10.2) 0.248 (*)
STK ‘Save the Kidney’, AKI Acute kidney injury, RRT Renal replacement therapy, ICU Intensive care unit, LoS Length of stay, IQR Inter quartile range, RR Relative risk,
CI Confidence interval. (*): p value considering difference between outcome in the usual care group and the STK group. (**) p value considering difference in AKI
incidence between both groups. (***) p value considering difference in AKI severity between both groups
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The AKI progression during the first 48 h after ICU ad-
mission was not different between the STK group and
the usual care group (Table 3 and Fig. 1b).
Secondary outcomes
ICU mortality
In the STK group 91 patients (6.8%) died during their
ICU admission compared to 72 patients (5.6%) in the
usual care group (RR 1.22, 95% confidence interval
0.90–1.64, p = 0.068) (Table 3).
Need for RRT
RRT was used in 22 patients (1.6%) in the STK group versus
46 patients (3.6%) in the usual care group RRT (RR 0.46,
95% confidence interval 0.28–0.76, p= 0.002) (Table 3).
AKI progression
Based on serum creatinine and urine output criteria 383
patients (28%) in the STK group developed AKI progres-
sion versus 311 patients (24%) in the usual care group
(RR 1.18, 95% confidence interval 1.04–1.35, p = 0.001).
AKI progression based on the separate components serum
creatinine and urine output is shown as supplementary mater-
ial (supplementary data 1 and supplementary table 1). The
sensitivity analysis showed that patients with diabetes mellitus
did not show a difference in outcome (supplementary table 2).
AKI severity
Based on serum creatinine and urine output AKI sever-
ity differed in the STK group compared with the usual
care group. In the STK group 299 patients (23%) had
stage 1 AKI and in the usual care group 238 patients
(18%). In the STK group 169 patients (13%) had stage 2
AKI and in the usual care group 128 patients (10%). In
the STK group 41 patients (3.2%) had stage 3 AKI and
in the usual care group 66 (5.1%) (p < 0.001) (Table 3).
AKI severity based on the separate components serum
creatinine and urine output is shown in the supplemen-
tary table 1.
ICU length of stay
Median ICU length of stay in the STK group was 2 days
[IQR 2–3] and in the usual care group also 2 days [IQR
2–3] (p = 0.319) (Table 3).
In-hospital mortality
In the STK group 137 patients (10%) died during their
hospitalisation and in the usual care group 117 patients
(9%) (RR 1.13, 95% confidence interval 0.89–1.42, p =
0.248) (Table 3).
Discussion
We used a pragmatic before-after design to test whether a
bundled approach targeted at prevention of AKI and a
reduction of AKI severity and AKI progression, intro-
duced at a department level impacts the outcome of critic-
ally ill patients. This study showed that implementation of
an educational ‘Save the Kidney bundle care in critically ill
patients aiming at a reduction of AKI had no beneficial ef-
fect on patient outcome when evaluated by a composite of
ICU mortality, the need for RRT and AKI progression.
These results are in contrast with the few studies that
evaluated AKI care bundles in hospitalized patients in
general or in patients after cardiac surgery [15, 16].
Those studies showed either a reduction in AKI inci-
dence and AKI severity in cardiac surgery patients or a
reduction in AKI incidence and a reduction in-hospital
mortality. Our study was not powered to detect signifi-
cance in individual components of the primary endpoint.
The primary outcome showed no benefit as a result of a
higher AKI incidence and contrary, a lower need for
RRT in the STK group (Table 3). In our study ICU mor-
tality was higher in the STK group, albeit non-
significant. Therewith, the effects of the implemented
bundle were contradictory, given the fact that need for
RRT is associated with a higher mortality.
Our results are also in contrast with other bundles in
critically ill patients such as the treatment bundle of the
Surviving Sepsis Campaign (SSC) to reduce mortality in
patients with sepsis or the bundle to reduce incidence of
ventilator associated pneumonia (VAP) in mechanically
ventilated critically ill patients [13, 14]. It is important to
note however that our study comprised an educational
intervention of which affects are often difficult to assess.
Strengths and limitations
Our study has several limitations. First, we did not record
which patients had the bundle applied in their treatment.
Besides that, we did not record which part of the bundle
was applied in which patients. It is possible that one of the
suggested interventions of the bundle has detrimental ef-
fects on the composite primary outcome, while others
may have positive effects. Moreover, not all interventions
were clearly described, but adjustments in antibiotic dose
were based on renal clearance and accordingly appropriate
drug dosing. This also holds for the optimization of the
fluid balance, physicians and nurses were stimulated to
critically evaluate the need for fluids. This was based on
the formulation of the KDIGO guidelines.
Second, we did not assess the full MAKE30 endpoint,
which was not published at the time. However, our pri-
mary endpoint was the composite of death, new renal
replacement therapy, or persistent renal dysfunction
which is recommended, as a patient-centered outcome
for pragmatic trials involving AKI.
Third, we did not analyse the compliance of the bundle
and furthermore, the same bundle can be implemented
differently by different clinicians. A recent study showed
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that using an interruptive AKI alert therapeutically inter-
ventions in patients increased from 7.9 to 28.7% of the pa-
tients [18]. Therefore, it is likely that the compliance of
this study was not 100%. Future research of our group and
others on the effect of AKI care bundles in critically ill pa-
tients need to address this issue.
Fourth, we did not correct for all previously reported
comorbidities, hence, differences in illness severity be-
tween groups may have played a role in our findings.
Furthermore, we had insufficient urine output data to
estimate AKI incidence and severity based on urine cri-
teria in nearly 20% of patients, with unequal amounts of
missing data between the two groups. This might have
led to underestimation of AKI incidence in the usual
care group since urine output is more sensitive in de-
tecting AKI than serum creatinine. This could have ex-
aggerated the (negative) effect of the care bundle. Last,
we did not collect baseline creatinine but estimated renal
function based on the assumption of a glomerular filtra-
tion rate of 75 l/min/1.73 m2.
A strength of this study is the prospective study design
with the inclusion of all patients, except for patients with
CKD, which reflects real life daily practice and patient
population. Even though this resulted in relatively low
median APACHE scores, AKI incidence was still high
and the KDIGO guidelines suggest that the measures
they advise may reduce AKI incidence in general.
No comparable studies have been performed in critic-
ally ill patients. We constructed an educational interven-
tion regarding bundled elements of AKI care as advised
by international guidelines. Each of the measures is sup-
ported by literature and guidelines suggest beneficial ef-
fects of bundled care. The results of our study show a
contradictory effect. This may be caused by limitations
of the current study or by chance, but it may also be the
result of the bundle itself. The simultaneously taken
measures rather than measures taken subsequently
might induce harm. A possible cause is for example the
reduced fluid resuscitation with possible adverse effects
on outcome due to – relative – hypovolemia. Also, the
reductions in antibiotic dosing propagated by the bundle
may have led to insufficient treatment of infections. This
may support therapeutic drug monitoring (TDM) [19].
In future research protocol adherence and effects of im-
plementation need to be studied.
Conclusion
Although more patients in the control group developed
stage 3 AKI compared to those in the STK intervention
group, providing education to uniformly apply an AKI
care bundle, without measurement of the implementa-
tion in a non-selected ICU population, targeted at pre-
vention of AKI progression was not beneficial.
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